Irish Clinical Research Infrastructure Network
REMEDI is committed to collaboration with hospitals and clinical facilities in achieving its translational goals. The vehicle for translating regenerative medical research into translational medicine is the Irish Clinical Research Infrastructure Network (ICRIN).
The Irish Clinical Research Infrastructure Network (ICRIN) was established in 2006 by five academic partners (NUI Galway, RCSI, TCD, UCC, UCD) and its preparatory phase is funded by the Health Research Board and the Health Service Executive with additional support from Enterprise Ireland.
ICRIN Vision
• Ireland as a country of choice for scientifically relevant multi-centre clinical studies and trials in specialist fields where partners are strong.
ICRIN Objectives
• Standardisation of approach to clinical research nationally through
– Research Readiness driving process harmonisation
– Clinical Research Education and Training
– Network development activities
• Support the establishment of disease networks
• Promoting a strategic approach to biobanking
• Development of a biomarker network
• Proposing strategic approaches to the development of a national infrastructure for clinical research.
• Enabling investigator-led, multi-centre clinical trials and other research activities by networking the clinical research centres of MMI’s five partner institutions and other research teams.
• Engaging as the Irish scientific partner of the European Clinical Research Infrastructure Network (ECRIN) and the Biobanking and Biomolecular Resources Research Infrastructure (BBMRI) to build a European infrastructure for academic-led clinical research and biobanking activities.
• Supporting indigenous innovators and small to medium enterprises (SMEs) in accessing the clinical resources they need to bring their products to market.
For further information, visit www.molecularmedicineireland.ie
